Nighttime skincare routine that is a must: Goodbye tired, dull skin, wake up to healthier, glowing skin
'Just like daytime skincare, nighttime also holds a lot of importance,' dermatologist Dr Shareefa Chause of Mumbai-based Dr Shareefa Skin care Clinic, tells HT Lifestyle.
Giving your skin consistent care at night can help you with the flawless skin that you have always dreamed of. Understand that nighttime skincare is equally important and shouldn't be missed at any cost.
'Your skin tends to repair and renew itself at night. It is the ideal time to nourish and treat your skin,' she adds. The right skincare before hitting the bed can boost hydration, reduce signs of ageing, and improve overall skin health. Dr Shareefa further adds that it is imperative to speak to the doctor and come up with an appropriate routine as per your requirements.
Nighttime skincare tips for glowing skin
Cleansing is necessary: Cleaning your skin is the first and most important part of the nighttime skincare routine. It is necessary to start by removing all makeup, dirt, and oil that have built up during the day. Opt for a gentle cleanser that suits your skin type to keep pores clean and prevent breakouts. Dr. Shareefa recommends not to rub the skin too hard; be gentle. Use a toner: Are you aware that a toner can help balance your skin's pH and tighten pores? Choose a toner as per your skin types and skin issues. Use an alcohol-free toner with soothing ingredients like rose water or green tea. Apply toner on a cotton swab and pat on your skin. This removes excess oil and removes any makeup or pollution residue from your skin. You can also include a toner spray to your skincare routine. Say YES to serum: Dr. Shareefa states that night is the best time to use serums that are loaded with active ingredients like vitamin C, hyaluronic acid, or niacinamide and retinoids. These ingredients target concerns like pigmentation, dryness, and fine lines, and enhance your skin texture. However, it's recommended that you use the serum as per your skin type. Don't just blindly use any products just because they are promoted on social media or come in fancy packaging. Use a moisturiser or night cream: Don't skip a moisturiser or a night cream, come what may! A nourishing moisturiser or a night cream enhances the hydration of the skin. Try to choose moisturisers or night creams with ingredients such as ceramides, peptides, or aloe vera, recommends Dr Shareefa. Eye cream: Under eye creams or patches are no less than a magic wand for your skin. These eye creams helps combat puffiness, dark circles, and fine lines. Eye creams generally have thicker consistency for the delicate under-eye region. These eye creams also boost hydration and keep your under-eye area supple and soft. Lip balm for soft lips: If you thought, nighttime skincare is only limited to your face, time to rethink! The skin of your lips are softer and tender as compared to your face, hence, it is important to sleep after applying a hydrating lip balm to keep your lips hydrated throughout the night.
So, the crux is, no matter what, don't skip your nighttime skincare ritual, be consistent and follow the routine religiously for optimal results.
Similar articles for you:
Does hairbrush impact your hair? Ranveer Singh's hair designer Darshan Yevelekar says so
Kareena Kapoor uses snail mucin! Here is what this Korean skincare ingredient is all about
How to clean your makeup brush and sponges for the ultimate hygiene check; Our detailed guide for you
Acne prone skin? Dr Blossom Kochhar recommends staying away from creamy products
Disclaimer: At Hindustan Times, we help you stay up-to-date with the latest trends and products. Hindustan Times has an affiliate partnership, so we may get a part of the revenue when you make a purchase. We shall not be liable for any claim under applicable laws, including but not limited to the Consumer Protection Act, 2019, with respect to the products. The products listed in this article are in no particular order of priority.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
an hour ago
- The Hindu
JNUSU president hospitalised amid ongoing hunger stir
Jawaharlal Nehru University Students' Union (JNUSU) president Nitish Kumar was hospitalised on Tuesday, the 12th day of an ongoing hunger strike, after he complained of chest pain, JNUSU members said. Students have been on an indefinite hunger strike demanding the reinstatement of the Jawaharlal Nehru University Entrance Examination (JNUEE), which has been replaced with a UGC-NET-based entrance system in recent years. The other demands include increasing the merit-cum-means scholarship and revocation of hostel eviction notices for PhD scholars on academic extension. Mr. Kumar, a member of the Left-affiliated All India Students' Association (AISA), was taken to Safdarjung Hospital. Loni, a JNU student and an AISA activist, who participated in the hunger strike, was also rushed to AIIMS on Tuesday afternoon after she blacked out. Both of them are said to be in stable condition. The JNUSU, in an open letter to the JNU Teachers' Association, stated that 14 students have been on hunger strike. 'Our principal demand is the restoration of the JNUEE. This exam has long ensured that this campus remains accessible to students from diverse backgrounds across the country. Its continuation is essential for safeguarding the inclusive character and academic integrity of JNU,' the letter read.
The Hindu
an hour ago
- The Hindu
Experts call for inclusion of Chronic Kidney Disease in national NCD programme
Hyderabad-based dialysis care network, NephroPlus, has urged policymakers to include Chronic Kidney Disease (CKD) screening in India's flagship National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD), as it released a white paper highlighting the rising burden of CKD across India and neighbouring countries. Speaking at a media briefing in Hyderabad on Tuesday, NephroPlus Group CEO Rohit Singh said the findings of the white paper and a large-scale screening initiative make a strong case for integrating CKD testing, particularly serum creatinine and urine albumin-to-creatinine ratio (ACR), into existing government-led screenings for hypertension and diabetes. 'The burden is silent but severe. CKD needs to be part of India's NCD strategy immediately,' he said. The paper is based on data from a kidney health screening campaign conducted in the lead-up to World Kidney Day in March. The campaign spanned 30 locations across India, the Philippines, and Uzbekistan, and covered 12 Indian States. A total of 10,501 persons pledged for kidney health awareness, of whom more than 5,000 underwent free serum creatinine and estimated glomerular filtration rate (eGFR) tests. NephroPlus found that several Indian States reported high prevalence of CKD risk factors. Jharkhand topped the list, followed by Haryana and Uttarakhand, Andhra Pradesh, Bihar, Delhi, Karnataka, Maharashtra, Uttar Pradesh, Telangana, Gujarat and Rajasthan. NephroPlus co-founder Kamal D. Shah stressed the economic and emotional toll of dialysis. 'Dialysis is not just a treatment; it is a lifelong ordeal that drains families physically, emotionally and financially. Our data shows that investing ₹1 in prevention saves ₹10 to ₹15 in future dialysis costs,' he said.
Time of India
2 hours ago
- Time of India
Pharma lobby flags 'cumbersome' export rule, seeks change
New Delhi: A significant dip in exports has prompted pharma lobby groups to raise a demand for changing the centralised no-object certification (NOC) provision for drug exports . The provision, which requires pharma companies to seek an approval from the national regulatory agency of the importing country or an NOC from the Indian regulator for shipments, has resulted in a drop in exports and diverted trade to other nations, industry executives told ET. The issue was raised in a meeting held on Monday at Niti Aayog . "Pharma exports have suffered due to the mismatch or an anomaly in newly introduced regulatory standards by the drug regulatory authority of India," said a person who attended the meeting. In early March, the Drugs Controller General of India (DCGI) updated the export NOC checklist in the wake of events such as the controversy over a Mumbai-based drugmaker allegedly exporting addictive opioid drugs to West African nations such as Ghana and Nigeria. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like What the Market May Be Getting Wrong About Nvidia Seeking Alpha Read More Undo However, the stringent norms have started hurting exports, industry insiders said. "Taking approvals from different regulatory bodies has only made the whole process cumbersome," the person cited above said. He noted that medicines are manufactured depending on the patient population construct. Live Events For example, Dolo and other paracetamol tablets are approved in India in strengths of 325mg, 500 mg and 650 mg while in Nigeria, it's approved for a strength of 1,000 mg. To manufacture and export that, Indian drugmakers now require an NOC from Nigerian authorities. The lobby groups have urged the government to review the provision as, according to them, this would divert trade to other nations with less stringent regulations. "Such a condition has imposed an undue burden on Indian exporters, potentially stifling innovation and hindering the export of unapproved/banned products especially for the MSME pharmaceutical sector, which is under tremendous strain with respect to compliance to domestic and international guidelines and trade barriers (tariffs & non-tariffs),' an industry expert said on condition of anonymity. The Niti Aayog had called pharma experts to undertake an analysis of the current state of the industry, to understand the challenges faced by drugmakers and initiatives taken by them to ensure production of safe and effective products. Nikkhil K Masurkar, chief executive of Entod Pharmaceuticals, said the official think tank's call for a quality overhaul is both "timely and necessary." "While India has made remarkable strides as a global pharma hub, maintaining consistent, internationally acceptable quality standards remains a key challenge, especially among MSME companies," he said. "The root of the problem often lies not in intent, but in outdated infrastructure, fragmented regulatory enforcement, and insufficient technical training," Masurkar said. "To produce world-class medicines, we must invest in continuous quality improvement, digitalise compliance systems, and empower our MSME sector with both financial and technical support."
